Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 24 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-36.70 Insider Own- Shs Outstand4.26M Perf Week-35.15%
Market Cap40.60M Forward P/E- EPS next Y-14.50 Insider Trans- Shs Float4.01M Perf Month-52.64%
Income-233.11M PEG- EPS next Q-2.15 Inst Own64.92% Short Float11.24% Perf Quarter-52.48%
Sales34.70M P/S1.17 EPS this Y75.35% Inst Trans- Short Ratio7.86 Perf Half Y-40.13%
Book/sh-20.43 P/B- EPS next Y9.86% ROA-99.76% Short Interest0.45M Perf Year-80.95%
Cash/sh9.47 P/C0.88 EPS next 5Y- ROE-2014.86% 52W Range4.97 - 63.38 Perf YTD-35.37%
Dividend Est.50.00 (603.50%) P/FCF- EPS past 5Y13.12% ROI- 52W High-86.93% Beta0.51
Dividend TTM- Quick Ratio0.50 Sales past 5Y25.21% Gross Margin57.34% 52W Low66.87% ATR (14)1.43
Dividend Ex-Date- Current Ratio0.59 EPS Y/Y TTM-1663.30% Oper. Margin-636.24% RSI (14)22.84 Volatility14.56% 10.63%
Employees225 Debt/Eq- Sales Y/Y TTM-39.63% Profit Margin-671.70% Recom2.67 Target Price104.38
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q-685.07% Payout- Rel Volume2.13 Prev Close8.23
Sales Surprise10.80% EPS Surprise10.39% Sales Q/Q2131.40% EarningsMay 09 AMC Avg Volume57.37K Price8.28
SMA20-37.29% SMA50-45.38% SMA200-60.31% Trades Volume122,277 Change0.67%
Date Action Analyst Rating Change Price Target Change
Nov-09-23Downgrade Mizuho Buy → Neutral $31 → $1
Nov-09-23Downgrade H.C. Wainwright Buy → Neutral
Nov-09-23Downgrade Evercore ISI Outperform → In-line
Jul-20-22Downgrade Citigroup Neutral → Sell $8 → $3
Jul-13-22Downgrade Stifel Buy → Hold $16 → $5
Jul-13-22Downgrade JP Morgan Overweight → Neutral $10
May-10-22Downgrade Citigroup Buy → Neutral $15 → $8
May-13-21Upgrade JP Morgan Neutral → Overweight $23 → $29
Dec-09-20Downgrade Citigroup Buy → Neutral $20 → $27
Dec-08-20Reiterated H.C. Wainwright Buy $28 → $31
Jun-21-24 04:01PM
Jun-17-24 08:00AM
Jun-12-24 07:00AM
Jun-11-24 07:00AM
Jun-07-24 04:01PM
04:01PM Loading…
Jun-05-24 04:01PM
May-29-24 04:01PM
May-20-24 11:57AM
May-09-24 10:57PM
May-03-24 04:01PM
Apr-05-24 04:01PM
01:53PM Loading…
Mar-28-24 01:53PM
Feb-29-24 09:05AM
Feb-28-24 04:30PM
Feb-14-24 09:00AM
Jan-31-24 06:30PM
Jan-11-24 01:26AM
Jan-08-24 09:00AM
Jan-04-24 04:01PM
Dec-20-23 04:01PM
Dec-11-23 12:00PM
04:01PM Loading…
Dec-01-23 04:01PM
Nov-29-23 06:05PM
Nov-24-23 12:29PM
Nov-22-23 04:01PM
Nov-10-23 04:01PM
Nov-09-23 08:23AM
Nov-08-23 05:35PM
Nov-05-23 12:50PM
Nov-02-23 05:42AM
Nov-01-23 08:35AM
Oct-06-23 04:01PM
Sep-21-23 09:19AM
Sep-19-23 04:01PM
Sep-01-23 04:01PM
Aug-31-23 04:01PM
Aug-13-23 10:44AM
Aug-08-23 05:30PM
Aug-04-23 04:01PM
Aug-01-23 04:01PM
Jul-31-23 04:01PM
Jul-29-23 11:07AM
Jul-17-23 07:29AM
Jul-07-23 04:01PM
Jun-16-23 06:05AM
Jun-07-23 04:01PM
Jun-05-23 09:00AM
Jun-02-23 04:01PM
May-18-23 07:09AM
May-08-23 05:15PM
May-07-23 08:59AM
May-05-23 04:01PM
May-01-23 04:01PM
Apr-16-23 12:08PM
Mar-31-23 04:01PM
Mar-24-23 09:35AM
Mar-03-23 04:01PM
Mar-01-23 04:01PM
Feb-21-23 04:01PM
Feb-15-23 06:58AM
Feb-08-23 05:15PM
Feb-06-23 08:00AM
Feb-03-23 04:01PM
Jan-13-23 04:01PM
Jan-04-23 04:01PM
Dec-24-22 10:07AM
Dec-20-22 04:33PM
Dec-19-22 08:00AM
Dec-15-22 04:01PM
Dec-12-22 10:00AM
Dec-02-22 04:01PM
Nov-23-22 08:00AM
Nov-22-22 05:03AM
Nov-10-22 05:52AM
Nov-09-22 04:01PM
Nov-08-22 05:15PM
Nov-04-22 04:01PM
Nov-01-22 04:05PM
Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company, which engages in the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. It also delivers off-the-shelf treatments to patients with high unmet medical need. Its product pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in Thousand Oaks, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Touchon PascalPresident and CEOMay 16 '24Sale0.6281,50650,2891,829,146May 20 08:34 PM
Nguyen AnhCoEVP, Chief Sci. & Tech OfficerMay 16 '24Sale0.6242,89926,469898,498May 20 08:34 PM
Murugan AmarEVP, Chief Legal OfficerMay 16 '24Sale0.6232,40119,991695,120May 20 08:33 PM
Hyllengren Eric JEVP, CFOMay 16 '24Sale0.6228,64817,676645,671May 20 08:33 PM
Henrich JillEVP, Global Head RA & QualityMay 16 '24Sale0.6225,75015,888529,251May 20 08:32 PM
Touchon PascalPresident and CEOMar 04 '24Sale0.7224,84417,8881,910,652Mar 06 06:19 PM
Nguyen AnhCoEVP, Chief Sci. & Tech OfficerMar 04 '24Sale0.7210,7467,737941,397Mar 06 06:18 PM
Murugan AmarEVP, Chief Legal OfficerMar 04 '24Sale0.7210,0447,232727,521Mar 06 06:18 PM
Henrich JillEVP, Global Head RA & QualityMar 04 '24Sale0.723,8792,793555,001Mar 06 06:16 PM
Touchon PascalPresident and CEONov 16 '23Sale0.3920,4097,939655,496Nov 20 05:31 PM
Joshi ManherEVP, Chief Medical OfficerNov 16 '23Sale0.3912,2874,780171,284Nov 20 05:30 PM
Hyllengren Eric JSVP, CFONov 16 '23Sale0.3911,9584,652205,998Nov 20 05:29 PM
Nguyen AnhCoEVP, Chief Sci. & Tech OfficerNov 16 '23Sale0.398,8563,445277,143Nov 20 05:31 PM
Murugan AmarEVP, Chief Legal OfficerNov 16 '23Sale0.398,3073,231257,084Nov 20 05:30 PM
Henrich JillEVP, Global Head RA & QualityNov 16 '23Sale0.393,2671,271104,424Nov 20 05:29 PM
Gallagher Carol GiltnerDirectorNov 14 '23Buy0.3190,98028,186459,418Nov 15 05:07 PM
Gallagher Carol GiltnerDirectorNov 13 '23Buy0.22179,02040,029368,438Nov 15 05:07 PM
DOBMEIER ERICDirectorNov 10 '23Buy0.23446,825101,340563,325Nov 14 06:27 PM
HEIDEN WILLIAM KDirectorNov 10 '23Buy0.25100,00025,330209,000Nov 14 06:29 PM
Touchon PascalPresident and CEOAug 16 '23Sale1.6530,76650,835675,905Aug 18 06:25 PM
Nguyen AnhCoEVP, Chief Sci. & Tech OfficerAug 16 '23Sale1.6515,12624,997285,999Aug 18 06:25 PM
Murugan AmarEVP, Chief Legal OfficerAug 16 '23Sale1.658,67214,330265,391Aug 18 06:25 PM
Hyllengren Eric JSVP, CFOAug 16 '23Sale1.658,18613,527217,956Aug 18 06:25 PM
Joshi ManherEVP, Chief Medical OfficerAug 16 '23Sale1.656,97511,526183,571Aug 18 06:25 PM
Henrich JillEVP, Global Head RA & QualityAug 16 '23Sale1.653,3465,531107,691Aug 18 06:25 PM
Touchon PascalPresident and CEOJun 27 '23Sale1.6614,29123,723706,671Jun 29 04:15 PM